In the News
In the News
Can drinking enough fluid via a “smart” water bottle help prevent recurrence of urinary stones? Peter Reese, MD, MSCE, and Greg Tasian, MD, MSc, MSCE, lead one of five centers in a new NIH-sponsored research network that will pursue The Prevention of Urinary Stones with Hydration (PUSH) study, a randomized clinical trial.
A physician’s “nudge” frames a set of choices to steer toward a particular option without shutting out other options. Scott Halpern, MD, PhD, M.Bioethics, believes this practice can improve the patient’s experience.
What can we learn from the clinical response to the 2014 Ebola outbreak in Africa? Susan Ellenberg, PhD, comments.
Recurrent cases of Clostridium difficile, the most common healthcare-linked infection in the U.S., are soaring, found James Lewis, MD, MSCE in a new study. How safe is our most promising treatment? “While we know that fecal microbiota transplantation is generally safe and effective in the short term, we need to establish the long-term safety of this procedure,” says Dr. Lewis.
We can safely offer 1,000 more transplant kidneys in the U.S. every year to people like Irma Hendricks, asserts David Goldberg, MD, MSCE in this NBC Nightly News coverage. A call from Peter Reese, MD, MSCE, changed Hendricks's life: "I can get you a transplant, but I'm going to have to give you hepatitis C to do it."
Mary Sammel, ScD, also works to improve people’s health and wellbeing as part of her personal life. She and her family are volunteer puppy raisers for The Seeing Eye, an organization that trains guide dogs for the visually impaired.
"The substantial variation in prescribing patterns of such extremely addictive medications for minor injuries results in many thousands of pills entering the community and places patients at an increased risk of continued use and potentially addiction," says lead author M. Kit Delgado, MD, MS.
Cigarette smokers may boost their risk of clogged heart arteries by weakening a gene that otherwise protects these important blood vessels, researchers have found. "This has been one of the first big steps towards solving the complex puzzle of gene-environment interactions that lead to coronary heart disease," said study lead author Danish Saleheen, PhD.
Can we dramatically increase the supply of transplant kidneys by using some that are hepatitis C infected, then eradicating the disease in the recipient? Peter Reese, MD, MSCE, and David S. Goldberg, MD, MSCE, report via early data that the answer appears to be yes.
“Instead of shooting arrows in the dark to find a drug that would be beneficial, we can now make an informed choice about the beneficial and harmful effects of pharmacological inhibition of a wide range of pathways,” comments Danish Saleheen, MBBS, PhD, one of the lead authors of a major study in Nature this week. An international research collaborative team studied more than 1,800 individuals who carried loss-of-function mutations in both copies of their genes, so-called “human knockouts."
To understand health and disease today, we need new thinking and novel science —the kind we create when multiple disciplines work together from the ground up. That is why this department has put forward a bold vision in population-health science: a single academic home for biostatistics, epidemiology and informatics. LEARN MORE ABOUT US